Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteomic approach to understanding antibiotic action.

Julia Elisabeth Bandow1, Heike Brötz, Lars Ingo Ole Leichert

  • 1Institut für Mikrobiologie, Ernst-Moritz-Arndt-Universität, 17489 Greifswald, Germany.

Antimicrobial Agents and Chemotherapy
|February 27, 2003
PubMed
Summary

Proteomic analysis of Bacillus subtilis reveals distinct cellular responses to antibiotics. This method aids in classifying novel compounds and advancing antibiotic drug discovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personality Traits and Their Association With Medication Non-Adherence in Patients With Multiple Sclerosis.

CNS neuroscience & therapeutics·2026
Same author

Polypharmacy, Potential Drug-Drug Interactions and Medication Non-Adherence in Patients with Multiple Sclerosis: A Longitudinal Study.

Neurology and therapy·2026
Same author

Bayes at the Bedside: Biomarkers in Situations of Clinical Uncertainty.

Diagnostics (Basel, Switzerland)·2026
Same author

Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.

The Lancet. Neurology·2026
Same author

Cost patterns of long-term prescribed medications in patients with multiple sclerosis in Germany.

Scientific reports·2025
Same author

The CYP152-family P450 enzyme CypC of Bacillus subtilis converts non-natural substrates in plasma-driven biocatalysis.

Applied microbiology and biotechnology·2025

Area of Science:

  • Microbiology
  • Proteomics
  • Drug Discovery

Background:

  • Understanding bacterial responses to antibiotics is crucial for developing new drugs.
  • Bacillus subtilis is a model organism for studying bacterial physiology and antibiotic action.

Purpose of the Study:

  • To use proteomic technology to understand Bacillus subtilis' complex cellular responses to various antibiotics.
  • To establish a protein expression database for Bacillus subtilis under antibiotic stress.
  • To classify novel antimicrobial compounds based on their protein expression profiles.

Main Methods:

  • Two-dimensional gel electrophoresis was used to create a comprehensive database of cytoplasmic proteins.
  • Protein synthesis during treatment with antibiotics or cell-damaging agents was analyzed.

Related Experiment Videos

  • Protein expression profiles were compared to identify similarities in drug mechanisms.

    • Main Results:

    • Each antibiotic elicited a unique protein expression profile in Bacillus subtilis.
    • Overlapping protein expression patterns indicated shared molecular drug mechanisms among antibiotics.
    • A novel protein synthesis inhibitor (BAY 50-2369) was successfully classified as a peptidyltransferase inhibitor.

    Conclusions:

    • Proteomic analysis provides new insights into bacterial responses to classical antibiotics.
    • This technique can help elucidate the mechanisms of action for novel antimicrobial compounds.
    • The described proteomic approach is valuable for antibiotic drug discovery and development.